Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis

被引:67
作者
Dhib-Jalbut, Suhayl [1 ]
机构
[1] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Neurol, New Brunswick, NJ 08901 USA
关键词
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ALTERED PEPTIDE LIGAND; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; REGULATORY T-CELLS; GLATIRAMER ACETATE; NEUROTROPHIC FACTOR; ADHESION MOLECULE; THERAPY; ACTIVATION;
D O I
10.1212/01.wnl.0000275228.13012.7b
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Substantial evidence supports autoimmune activity as the etiologic mechanism underlying multiple sclerosis (MS). Both the innate and the adaptive arms of the immune system are involved in the aberrant response to several antigens associated with the myelin sheath and oligodendrocytes (OGCs) after the activation of immune cells by self- or cross-reactive microbial pathogens. The CD4(+) Th1 cell, in particular, has been implicated, but it is abetted by a variety of other cell types (CD8(+) cells, B cells, macrophages, and microglia) and soluble products (proteases, cytokines, and nitric oxide [NO]) that act both outside of and within the CNS. This review describes recent and salient findings from animal models and human clinical studies that have established our current understanding of the distinct steps in the development of immune autoreactivity that culminates in the CNS lesions associated with MS.
引用
收藏
页码:S13 / S21
页数:9
相关论文
共 45 条
  • [1] Fc receptors are critical for autoimmune inflammatory damage to the central nervous system in experimental autoimmune encephalomyelitis
    Abdul-Majid, KB
    Stefferl, A
    Bourquin, C
    Lassmann, H
    Linington, C
    Olsson, T
    Kleinau, S
    Harris, RA
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2002, 55 (01) : 70 - 81
  • [2] Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ
    Aharoni, R
    Kayhan, B
    Eilam, R
    Sela, M
    Arnon, R
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) : 14157 - 14162
  • [3] Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy
    Allie, R
    Hu, L
    Mullen, KM
    Dhib-Jalbut, S
    Calabresi, PA
    [J]. ARCHIVES OF NEUROLOGY, 2005, 62 (06) : 889 - 894
  • [5] Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
    Barnett, MH
    Prineas, JW
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (04) : 458 - 468
  • [6] Antimyelin antibodies as a predictor of clinically definite multiple sclerosis after a first demyelinating event
    Berger, T
    Rubner, P
    Schautzer, F
    Egg, R
    Ulmer, H
    Mayringer, I
    Dilitz, E
    Deisenhammer, F
    Reindl, M
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (02) : 139 - 145
  • [7] Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand
    Bielekova, B
    Goodwin, B
    Richert, N
    Cortese, I
    Kondo, T
    Afshar, G
    Gran, B
    Eaton, J
    Antel, J
    Frank, JA
    McFarland, HF
    Martin, R
    [J]. NATURE MEDICINE, 2000, 6 (10) : 1167 - 1175
  • [8] Targeting leukocyte MMPs and transmigration - Minocycline as a potential therapy for multiple sclerosis
    Brundula, V
    Rewcastle, NB
    Metz, LM
    Bernard, CC
    Yong, VW
    [J]. BRAIN, 2002, 125 : 1297 - 1308
  • [9] THE ADHESION MOLECULE AND CYTOKINE PROFILE OF MULTIPLE-SCLEROSIS LESIONS
    CANNELLA, B
    RAINE, CS
    [J]. ANNALS OF NEUROLOGY, 1995, 37 (04) : 424 - 435
  • [10] Mechanisms of disease - The many roles of chemokines and chemokine receptors in inflammation
    Charo, IF
    Ransohoff, RM
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (06) : 610 - 621